Literature DB >> 993091

Cytotoxicity of two nitroimidazole radiosensitizers in an in vitro tumor model.

R Sridhar, C Koch, R Suterland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 993091     DOI: 10.1016/0360-3016(76)90088-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  15 in total

Review 1.  Optimizing hypoxia detection and treatment strategies.

Authors:  Cameron J Koch; Sydney M Evans
Journal:  Semin Nucl Med       Date:  2015-03       Impact factor: 4.446

2.  Cytotoxicity of glucose analogues in V79 multicell spheroids.

Authors:  R Sridhar; E C Stroude; W R Inch
Journal:  In Vitro       Date:  1979-09

Review 3.  Multicellular spheroids. A review on cellular aggregates in cancer research.

Authors:  W Mueller-Klieser
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

4.  Cytotoxicity of radiosensitizers in multicell spheroids: combination treatment with hyperthermia.

Authors:  R Sutherland; W Macfarlane
Journal:  Br J Cancer Suppl       Date:  1978-06

5.  Enhancement of local tumour control by misonidazole and hyperthermia.

Authors:  H B Stone
Journal:  Br J Cancer Suppl       Date:  1978-06

6.  Cell survival in V79 multicell spheroids treated with dehydroascorbate, 5-thio-D-glucose and 2-deoxy-D-glucose.

Authors:  R Sridhar; C J Koch; E C Stroude; W R Inch
Journal:  Br J Cancer Suppl       Date:  1978-06

7.  Some factors affecting the specific toxicity of misonidazole towards hypoxic mammalian cells.

Authors:  I J Stratford; P Gray
Journal:  Br J Cancer Suppl       Date:  1978-06

8.  Cytotoxicity of metronidazole (Flagyl) and misonidazole (Ro-07-0582): enhancement by lactate.

Authors:  J S Mahood; R L Willson
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

9.  Split dose cytotoxic experiments with misonidazole.

Authors:  I J Stratford
Journal:  Br J Cancer       Date:  1978-07       Impact factor: 7.640

10.  In vivo combination of misonidazole and the chemotherapeutic agent CCNU.

Authors:  D W Siemann
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.